{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:33:00Z","timestamp":1791973980022,"version":"4.4.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T00:00:00Z","timestamp":1613433600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000779","name":"University of London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000779","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019125","name":"Sorbonne Universit\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019125","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.omtn.2021.02.017","type":"journal-article","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T11:38:19Z","timestamp":1613907499000},"page":"67-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["BB-301: a silence and replace AAV-based vector for the treatment of oculopharyngeal muscular dystrophy"],"prefix":"10.1016","volume":"24","author":[{"given":"Vanessa","family":"Strings-Ufombah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0536-5231","authenticated-orcid":false,"given":"Alberto","family":"Malerba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6294-5494","authenticated-orcid":false,"given":"Shih-Chu","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonal","family":"Harbaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ornella","family":"Cappellari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7241-9607","authenticated-orcid":false,"given":"Ngoc","family":"Lu-Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9229-4880","authenticated-orcid":false,"given":"Sophie","family":"Mukadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina","family":"Kilfoil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Kloth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petrus","family":"Roelvink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4838-3712","authenticated-orcid":false,"given":"Capucine","family":"Trollet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Suhy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2021.02.017_bib1","first-page":"326","article-title":"Oropharyngeal dysphagia in patients with oculopharyngeal muscular dystrophy","volume":"21","author":"Duranceau","year":"1978","journal-title":"Can. J. Surg."},{"issue":"Suppl 1","key":"10.1016\/j.omtn.2021.02.017_bib2","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1016\/S0960-8966(97)00091-6","article-title":"Dysphagia in oculopharyngeal muscular dystrophy: a series of 22 French cases","volume":"7","author":"P\u00e9ri\u00e9","year":"1997","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtn.2021.02.017_bib3","series-title":"Gene Reviews","first-page":"1","article-title":"Oculopharyngeal Muscular Dystrophy","author":"Trollet","year":"2014"},{"key":"10.1016\/j.omtn.2021.02.017_bib4","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng0298-164","article-title":"Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy","volume":"18","author":"Brais","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtn.2021.02.017_bib5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/2044-5040-3-23","article-title":"Control of mRNA stability contributes to low levels of nuclear poly(A) binding protein 1 (PABPN1) in skeletal muscle","volume":"3","author":"Apponi","year":"2013","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.omtn.2021.02.017_bib6","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1017\/S0317167100018588","article-title":"An 18 alanine repeat in a severe form of oculopharyngeal muscular dystrophy","volume":"41","author":"Jouan","year":"2014","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.omtn.2021.02.017_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF00692226","article-title":"Nuclear inclusions in oculopharyngeal dystrophy","volume":"49","author":"Tom\u00e9","year":"1980","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.omtn.2021.02.017_bib8","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/NEN.0b013e3182854c07","article-title":"Atrophy, fibrosis, and increased PAX7-positive cells in pharyngeal muscles of oculopharyngeal muscular dystrophy patients","volume":"72","author":"Gidaro","year":"2013","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.omtn.2021.02.017_bib9","doi-asserted-by":"crossref","first-page":"10706","DOI":"10.1093\/nar\/gkx786","article-title":"Nuclear poly(A) binding protein 1 (PABPN1) and Matrin3 interact in muscle cells and regulate RNA processing","volume":"45","author":"Banerjee","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2021.02.017_bib10","doi-asserted-by":"crossref","first-page":"412","DOI":"10.18632\/aging.100567","article-title":"A decline in PABPN1 induces progressive muscle weakness in oculopharyngeal muscle dystrophy and in muscle aging","volume":"5","author":"Anvar","year":"2013","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.omtn.2021.02.017_bib11","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1093\/hmg\/ddx206","article-title":"Novel mouse models of oculopharyngeal muscular dystrophy (OPMD) reveal early onset mitochondrial defects and suggest loss of PABPN1 may contribute to pathology","volume":"26","author":"Vest","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2021.02.017_bib12","doi-asserted-by":"crossref","first-page":"14848","DOI":"10.1038\/ncomms14848","article-title":"PABPN1 gene therapy for oculopharyngeal muscular dystrophy","volume":"8","author":"Malerba","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2021.02.017_bib13","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/nm1242","article-title":"Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice","volume":"11","author":"Davies","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2021.02.017_bib14","doi-asserted-by":"crossref","first-page":"e1005092","DOI":"10.1371\/journal.pgen.1005092","article-title":"Mitochondrial dysfunction reveals the role of mRNA poly(A) tail regulation in oculopharyngeal muscular dystrophy pathogenesis","volume":"11","author":"Chartier","year":"2015","journal-title":"PLoS Genet."},{"key":"10.1016\/j.omtn.2021.02.017_bib15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/6981","article-title":"Synthetic muscle promoters: activities exceeding naturally occurring regulatory sequences","volume":"17","author":"Li","year":"1999","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2021.02.017_bib16","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/70718","article-title":"Myogenic expression of an injectable protease-resistant growth hormone-releasing hormone augments long-term growth in pigs","volume":"17","author":"Draghia-Akli","year":"1999","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2021.02.017_bib17","doi-asserted-by":"crossref","first-page":"9163","DOI":"10.1128\/JVI.00282-12","article-title":"Impact of VP1-specific protein sequence motifs on adeno-associated virus type 2 intracellular trafficking and nuclear entry","volume":"86","author":"Popa-Wagner","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2021.02.017_bib18","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.ymthe.2005.08.018","article-title":"Successful production of pseudotyped rAAV vectors using a modified baculovirus expression system","volume":"12","author":"Kohlbrenner","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2021.02.017_bib19","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1038\/mtna.2013.73","article-title":"Deep sequencing insights in therapeutic shRNA processing and siRNA target cleavage precision","volume":"3","author":"Denise","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2021.02.017_bib20","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1038\/mt.2012.119","article-title":"Safe, long-term hepatic expression of anti-HCV shRNA in a nonhuman primate model","volume":"20","author":"Suhy","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2021.02.017_bib21","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000105812","article-title":"Diabetes provides an unfavorable environment for muscle mass and function after muscle injury in mice","volume":"74","author":"Vignaud","year":"2007","journal-title":"Pathobiology"},{"key":"10.1016\/j.omtn.2021.02.017_bib22","doi-asserted-by":"crossref","first-page":"14258","DOI":"10.1073\/pnas.1109522108","article-title":"Combination therapy utilizing shRNA knockdown and an optimized resistant transgene for rescue of diseases caused by misfolded proteins","volume":"108","author":"Li","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2021.02.017_bib23","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.ymthe.2017.09.020","article-title":"Survival Advantage of Both Human Hepatocyte Xenografts and Genome-Edited Hepatocytes for Treatment of \u03b1-1 Antitrypsin Deficiency","volume":"25","author":"Borel","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2021.02.017_bib24","doi-asserted-by":"crossref","first-page":"E8547","DOI":"10.1073\/pnas.1805055115","article-title":"Mutation-independent rhodopsin gene therapy by knockdown and replacement with a single AAV vector","volume":"115","author":"Cideciyan","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2021.02.017_bib25","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.1073\/pnas.0801775105","article-title":"Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi","volume":"105","author":"McBride","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2021.02.017_bib26","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1093\/hmg\/ddq098","article-title":"Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres","volume":"19","author":"Trollet","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2021.02.017_bib27","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/hum.2018.015","article-title":"Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN","volume":"29","author":"Hinderer","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2021.02.017_bib28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14806\/ej.17.1.200","article-title":"Cutadapt Removes Adapter Sequences From High-Throughput Sequencing Reads","volume":"17","author":"Martin","year":"2011","journal-title":"EMBnet. J."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253121000524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253121000524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:48:58Z","timestamp":1788540538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253121000524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":28,"alternative-id":["S2162253121000524"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2021.02.017","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BB-301: a silence and replace AAV-based vector for the treatment of oculopharyngeal muscular dystrophy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2021.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors.","name":"copyright","label":"Copyright"}]}}